Assessment of hepatic reserve for indication of hepatic resection: Decision tree incorporating indocyanine green test

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 12, Issue 1, 2005, Pages 16-22

  Imamura, Hiroshi ^a   Sano, Keiji ^a   Sugawara, Yasuhiko ^a   Kokudo, Norihiko ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Hepatic functional reserve; Indocyanine green; Operative mortality; Postoperative liver failure; Safe limit of hepatectomy

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; BILE ACID; BILIRUBIN; BLOOD CLOTTING FACTOR; GAMMA GLUTAMYLTRANSFERASE; INDOCYANINE GREEN;

ARTICLE; ASCITES; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; DISEASE CLASSIFICATION; ENUCLEATION; FEASIBILITY STUDY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER PARENCHYMA; LIVER RESECTION; MEDICAL DECISION MAKING; MORTALITY; PREDICTION; PREOPERATIVE EVALUATION; QUANTITATIVE ANALYSIS; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT INDICATION;

ASCITES; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; COLORING AGENTS; DECISION TREES; HEPATECTOMY; HUMANS; INDOCYANINE GREEN; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; PATIENT SELECTION;

EID: 15044356402     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-004-0965-9     Document Type: Article

References (39)

1. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298-304
2. Zimmermann H, Reichen J (2000) Assessment of the liver function in the surgical patient. In: Blumgart LH, Fong Y (eds) Surgery of the liver and biliary tract. Saunders, London, pp 35-64
3. Wilkinson G, Shand D (1975) A physiological apptroach to hepatic drug clearance. Clin Pharmacol Ther 18:377-390
4. Keiding S (1987) Hepatic clearance and liver blood flow. J Hepatol 4:393-398
5. Kawasaki S, Sugiyama Y, Iga T, Hanano M, Beppu T, Sugiura M, Sanjo K, Idezuki Y (1988) Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver disease. Clin Pharmacol Ther 44:217-214
6. Greenblatt DJ, Koch-Weser J (1975) Drug therapy. Clinical pharmacokinetics 1. N Engl J Med 293:702-705
7. Kawasaki S, Sugiyama Y, Iga T, Hanano M, Sanjo K, Beppu T, Idezuki Y (1985) Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients. Am J Gastroenterol 80:801-806
8. Pessayre D, Lebrec D, Descantoire V, Peignoux M, Benhamou JP (1978) Mechanism for reduced drug clearance in patients with cirrhosis. Gastroenterology 74:566-571
9. Leevy CM, Mendenhall CL, Lesko W, Howard MM (1962) Estimation of hepatic blood flow with indocyanine green. J Clin Invest 41:1169-1180
10. Wood AJJ, Villeneuve JP, Branch RA, Rogers LW, Shand DG (1979) Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat. Gastroenterology 76:1358-1362
11. Popper H, Elias H, Petty DE (1952) Vascular pattern of the cirrhotic liver. Am J Clin Pathol 22:717-729
12. Huet PM, Goresky CA, Villeneuve JP, Marleau D, Lough JO (1982) Assessment of liver microcirculation in human cirrhosis. J Clin Invest 70:109-113
13. Reichen J, Egger B, Ohara N, Zeltner T, Zysset T, Zimmermann A (1988) Determinant of hepatic functions in liver cirrhosis in the rat: A multivariate analysis. J Clin Invest 82:2069-2076
14. Schaffner F, Popper H (1963) Capillarization of hepatic sinusoids. Gastroenterology 44:239-242
15. Varin F, Huet PM (1985) Hepatic microcirculation in the perfused cirrhotic rat liver. J Clin Invest 76:1904-1912
16. Child CG, Turcotte JC (1964) Surgery and portal hypertension. In: Child CG (ed) The liver and portal hypertension. Saunders, Philadelphia, pp 50-51
17. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transsection for the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-649
18. Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161:346-350
19. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, Makuuchi M, Kawasaki S (1999) Preoperative portal vein embolization: An audit of 84 patients. Hepatology 29:1099-1105
20. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, Harihara Y, Takayama T (1997) Measurement of liver volume and hepatic functional reserve as a guide to decisionmaking in resectional surgery for hepatic tumors. Hepatology 26:1176-1181
21. Cameron JL, Zuidema GD, Smith GW, Harrington DP, Maddrey WC (1979) Mesocaval shunts for the control of bleeding esophageal varices. Surgery (St. Louis) 85:257-262
22. C-aminopyrine breath test compared to the Child-Pugh score and serum bile acids in 84 cirrhotic patients. Digestion 50:212-218
23. Grace ND, Conn O, Resnick RH, Groszmann RJ, Atterbury CE, Wright SC, Gusberg RJ, Vollman R, Garcia-Tsao G, Fisher RL (1988) Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: A randomized controlled trial. Hepatology 8:1275-1481
24. Henderson JM, Kutner MH, Millikan WJ, Galambos JT, Riepe SP, Brooks WS, Bryan FC, Warren WD (1990) Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. Ann Intern Med 112:262-269
25. Christensen E, Schlichting P, Fauerholdt L, Gluud C, Andersen P, Juhl E, Poulsen H, Tygstrup N (1984) Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 4:430-435
26. Infante-Rivard C, Esnaola S, Villeneuve JP (1987) Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 7:660-664
27. Imamura H, Seyama Y, Kokudo N, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198-1206
28. Kawasaki S, Makuuchi M, Matsunami H, Hashikura Y, Ikegami T, Chisuwa H, Ikeno T, Noike T, Takayama T, Kawarazaki H (1993) Preoperative measurement of segmental liver volume of donors for living related liver transplantation. Hepatology 18:1115-1120
29. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84:1255-1259
30. Hsia CY, Lui WY, Chau GY, King KL, Loong CC, Wu CW (2000) Perioperative safety and prognosis in hepatocellular carcinoma patients with impaired liver function. J Am Coll Surg 190:574-579
31. Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR (1992) Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 163:515-518
32. Nonami T, Nakao A, Kurokawa T, Inagaki H, Matsushita Y, Sakamoto J, Takagi H (1999) Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepato-Gastroenterology 46:1669-1672
33. Ishikawa M, Yogita S, Miyake H, Fukuda Y, Harada M, Wada D, Tashiro S (2002) Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma. Hepato-Gastroenterology 49:1625-1631
34. Yamanaka N, Okamoto E, Oriyama T, Fujimoto J, Furukawa K, Kawamura E, Tanaka T, Tomoda F (1994) A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 219:342-346
35. Finch MD, Crosbie JL, Currie R, Garden OJ (1998) An 8-year experience of hepatic resection: Indications and outcome. Br J Surg 85:315-319
36. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O (2000) Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38-46
37. Taylor M, Forster J, Langer B, Taylor BR, Greig PD, Mahut C (1997) A study of prognostic factors for hepatic resection for colorectal cancer. Am J Surg 84:1136-1140
38. Holom A, Bradley E, Aldrete JS (1989) Hepatic resection of metastasis from colorectal carcinoma. Morbidity, mortality, and pattern of recurrence. Ann Surg 209:428-434
39. Hasegawa K, Imamura H, Akahane M, Miura Y, Kiryu S, Ohtomo K, Makuuchi M (2004) Administration of iodized oil resulted in impaired liver function due to enhanced portosystemic shunting. Cardio-Vascular Intervent Radiol 27:282-284